术前抗生素是否应根据患者合并症和微生物易感性进行个体化选择?
基于1022例假体周围感染(PJI)和8575例初次全关节置换术数据,评估合并症对PJI微生物谱的影响及头孢唑林与万古霉素预防效果的差异。转移性疾病、充血性心力衰竭、慢性肺病和糖尿病与抗生素耐药微生物相关,但合并症分层后两种抗生素的PJI发生率无差异。结果支持当前通用抗生素预防方案而非按合并症个体化。
要点
- 转移性疾病(OR 5.71)、充血性心力衰竭(OR 2.2)、慢性肺病(OR 1.76)和糖尿病(OR 1.66)与抗生素耐药微生物相关。
- 无合并症与革兰阳性或革兰阴性感染率增加相关。
- 在糖尿病、类风湿关节炎、肝病和甲状腺功能减退分层中,头孢唑林与万古霉素单药治疗的PJI发生率无差异。
核心结论
- 本研究结果支持当前通用抗生素预防方案的推荐,而非根据患者合并症个体化选择抗生素方案。
研究设计与样本
- 利用包含1022例PJI的机构数据库评估不同患者合并症对微生物谱的影响。
- 识别8575例初次全关节置换术,交叉匹配PJI,并根据队列合并症分析围手术期抗生素(头孢唑林或万古霉素单药)对PJI率的影响。
主要发现
- 转移性疾病(OR 5.71,P=0.018)、充血性心力衰竭(OR 2.2,P=0.010)、慢性肺病(OR 1.76,P=0.015)和糖尿病(OR 1.66,P=0.019)与抗生素耐药微生物相关。
- 无合并症与革兰阳性感染率或革兰阴性感染率增加相关。
- 在糖尿病、类风湿关节炎、肝病和甲状腺功能减退分层中,头孢唑林与万古霉素单药治疗的PJI率无差异。
关键数值与推荐
- 转移性疾病与抗生素耐药微生物的OR为5.71(P=0.018)。
- 充血性心力衰竭与抗生素耐药微生物的OR为2.2(P=0.010)。
- 慢性肺病与抗生素耐药微生物的OR为1.76(P=0.015)。
- 糖尿病与抗生素耐药微生物的OR为1.66(P=0.019)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preoperative antibiotic prophylaxis remains one of the most important strategies for preventing periprosthetic joint infection (PJI). Current guidelines recommend giving universal antibiotic prophylaxis to all total joint arthroplasty patients regardless of their medical conditions or immune status; however, no studies have evaluated the individualizing of antibiotics. The aims of this study were (1) to determine if comorbidities influence the organism profile of PJIs, and (2) to investigate if the efficacy of two different perioperative antibiotics (cefazolin or vancomycin) for preventing PJI is affected by patient's comorbidities. METHODS: Using an institutional database of 1022 PJIs, the influence of different patient's comorbidities on the organism profile was evaluated. To investigate the influence of perioperative antibiotics (cefazolin or vancomycin monotherapy) on PJI rate, 8575 primary total joint arthroplasties were identified, crossmatched for PJI, and analyzed based on the comorbidities of the cohort. The PJI rate of each antibiotic within each comorbidity was compared. RESULTS: Although no comorbidities were associated with an increased rate of Gram-positive infections or Gram-negative infections, metastatic disease (odds ratio [OR] 5.71, P = .018), congestive heart failure (OR 2.2, P = .010), chronic pulmonary disease (OR 1.76, P = .015), and diabetes mellitus (OR 1.66, P = .019) were associated with antibiotic resistant organisms. However, there was no difference in the PJI rate between cefazolin and vancomycin monotherapy when stratifying for diabetes mellitus, rheumatoid arthritis, liver disease, and hypothyroidism. CONCLUSION: The results of the present study support the current recommendations of a universal antibiotic prophylaxis protocol rather than an antibiotic regimen individualized to a patient's comorbidities.
引用
- Tan TL, Gomez MM, Kheir MM, et al. Should Preoperative Antibiotics Be Tailored According to Patient's Comorbidities and Susceptibility to Organisms? J Arthroplasty. 2016. PMID: 28040397. doi:10.1016/j.arth.2016.11.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。